|
1
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273 e1261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Negro F, Forton D, Craxi A, Sulkowski MS,
Feld JJ and Manns MP: Extrahepatic morbidity and mortality of
chronic hepatitis C. Gastroenterology. 149:1345–1360. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang L, Marcell L and Kottilil S: Systemic
manifestations of hepatitis C infection. Infect Agent Cancer.
11:292016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sherman AC and Sherman KE: Extrahepatic
manifestations of hepatitis C infection: Navigating CHASM. Curr
HIV/AIDS Rep. 12:353–361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gill K, Ghazinian H, Manch R and Gish R:
Hepatitis C virus as a systemic disease: Reaching beyond the liver.
Hepatol Int. 10:415–423. 2016. View Article : Google Scholar :
|
|
6
|
Zignego AL, Gragnani L, Piluso A,
Sebastiani M, Giuggioli D, Fallahi P, Antonelli A and Ferri C:
Virus-driven autoimmunity and lymphoproliferation: The example of
HCV infection. Expert Rev Clin Immunol. 11:15–31. 2015. View Article : Google Scholar
|
|
7
|
Nuno Solinis R, Arratibel Ugarte P, Rojo A
and Sanchez Gonzalez Y: Value of treating all stages of chronic
hepatitis C: A comprehensive review of clinical and economic
evidence. Infect Dis Ther. 5:491–508. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee CM, Hung CH, Lu SN and Changchien CS:
Hepatitis C virus genotypes: Clinical relevance and therapeutic
implications. Chang Gung Med J. 31:16–25. 2008.PubMed/NCBI
|
|
9
|
Waldron PR and Holodniy M: MicroRNA and
hepatitis C virus - challenges in investigation and translation: A
review of the literature. Diagn Microbiol Infect Dis. 80:1–12.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rahman W, Tu T, Budzinska M, Huang P,
Belov L, Chrisp JS, Christopherson RI, Warner FJ, Bowden DS,
Thompson AJ, et al: Analysis of post-liver transplant hepatitis C
virus recurrence using serial cluster of differentiation antibody
microarrays. Transplantation. 99:e120–e126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Woodhouse SD, Narayan R, Latham S, Lee S,
Antrobus R, Gangadharan B, Luo S, Schroth GP, Klenerman P and
Zitzmann N: Transcriptome sequencing, microarray, and proteomic
analyses reveal cellular and metabolic impact of hepatitis C virus
infection in vitro. Hepatology. 52:443–453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blackham S, Baillie A, Al-Hababi F,
Remlinger K, You S, Hamatake R and McGarvey MJ: Gene expression
profiling indicates the roles of host oxidative stress, apoptosis,
lipid metabolism, and intracellular transport genes in the
replication of hepatitis C virus. J Virol. 84:5404–5414. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papic N, Maxwell CI, Delker DA, Liu S,
Heale BS and Hagedorn CH: RNA-sequencing analysis of 5′ capped RNAs
identifies many new differentially expressed genes in acute
hepatitis C virus infection. Viruses. 4:581–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Walters KA, Syder AJ, Lederer SL, Diamond
DL, Paeper B, Rice CM and Katze MG: Genomic analysis reveals a
potential role for cell cycle perturbation in HCV-mediated
apoptosis of cultured hepatocytes. PLoS Pathog. 5:e10002692009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cai B and Jiang X: Revealing biological
pathways implicated in lung cancer from TCGA gene expression data
using gene set enrichment analysis. Cancer Inform. 13:113–121.
2014.PubMed/NCBI
|
|
16
|
Hira ZM and Gillies DF: A Review of
feature selection and feature extraction methods applied on
microarray data. Adv Bioinformatics. 2015:1983632015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Braun R: Systems analysis of
high-throughput data. Adv Exp Med Biol. 844:153–187. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng ZG, Zhao ZY, Li YP, Wang YP, Hao LH,
Fan B, Li YH, Wang YM, Shan YQ, Han YX, et al: Host apolipoprotein
B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an
innate defensive factor and drug target against hepatitis C virus.
Hepatology. 53:1080–1089. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carlson M: Agilent 'Human Genome, Whole'
annotation data (chip hgug4112a). R package version 3.2.3. 2016
|
|
21
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Robyr R, Boulvain M, Lewi L, Huber A,
Hecher K, Deprest J and Ville Y: Cervical length as a prognostic
factor for preterm delivery in twin-to-twin transfusion syndrome
treated by fetoscopic laser coagulation of chorionic plate
anastomoses. Ultrasound Obstet Gynecol. 25:37–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnson WE, Li C and Rabinovic A:
Adjusting batch effects in microarray expression data using
empirical Bayes methods. Biostatistics. 8:118–127. 2007. View Article : Google Scholar
|
|
24
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carlson M, Falcon S, Pages H and Li N:
KEGG.db: A set of annotation maps for KEGG. KEGG.db. 2012.
|
|
26
|
Draghici ALTaPKaS: SPIA: Signaling Pathway
Impact Analysis (SPIA) using combined evidence of pathway
over-representation and unusual signaling perturbations. (R package
version 2.28.0). 2013
|
|
27
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tarca AL, Draghici S, Khatri P, Hassan SS,
Mittal P, Kim J, Kim CJ, Kusanovic JP and Romero R: A novel
signaling pathway impact analysis. Bioinformatics. 25:75–82. 2009.
View Article : Google Scholar :
|
|
29
|
Jelier R, Schuemie MJ, Veldhoven A,
Dorssers LC, Jenster G and Kors JA: Anni 2.0: A multipurpose
text-mining tool for the life sciences. Genome Biol. 9:R962008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo W and Brouwer C: Pathview: An
R/Bioconductor package for pathway-based data integration and
visualization. Bioinformatics. 29:1830–1831. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Muffak-Granero K, Bueno P, Olmedo C,
Comino AM, Hassan L, Garcia-Alcalde F, Serradilla M, García-Navarro
A, Mansilla A, Villar JM, et al: Study of gene expression profile
in liver transplant recipients with hepatitis C virus. Transplant
Proc. 40:2971–2974. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi SS, Bradrick S, Qiang G, Mostafavi A,
Chaturvedi G, Weinman SA, Diehl AM and Jhaveri R: Up-regulation of
Hedgehog pathway is associated with cellular permissiveness for
hepatitis C virus replication. Hepatology. 54:1580–1590. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haynes WA, Higdon R, Stanberry L, Collins
D and Kolker E: Differential expression analysis for pathways. PLOS
Comput Biol. 9:e10029672013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cacoub P and Comarmond C: New insights
into HCV-related rheumatologic disorders: A review. J Adv Res.
8:89–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Petterson T, Jendholm J, Månsson A,
Bjartell A, Riesbeck K and Cardell LO: Effects of NOD-like
receptors in human B lymphocytes and crosstalk between NOD1/NOD2
and Toll-like receptors. J Leukoc Biol. 89:177–187. 2011.
View Article : Google Scholar
|
|
36
|
Modaresi Esfeh J and Ansari-Gilani K:
Steatosis and hepatitis C. Gastroenterol Rep (Oxf). 4:24–29.
2016.
|
|
37
|
Demir M and Demir C: Effect of hepatitis C
virus infection on the left ventricular systolic and diastolic
functions. South Med J. 104:543–546. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nam YJ, Kim SJ, Shin WC, Lee JH, Choi WC,
Kim KY and Han TH: Gastric pH and Helicobacter pylori infection in
patients with liver cirrhosis. Korean J Hepatol. 10:216–222.
2004.In Korean. PubMed/NCBI
|
|
39
|
Saunders J, Cargill J and Wormsley K:
Gastric secretion of acid in patients with pancreatic disease.
Digestion. 17:365–369. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Carrière F, Grandval P, Renou C, Palomba
A, Priéri F, Giallo J, Henniges F, Sander-Struckmeier S and Laugier
R: Quantitative study of digestive enzyme secretion and
gastrointestinal lipolysis in chronic pancreatitis. Clin
Gastroenterol Hepatol. 3:28–38. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Masini M, Campani D, Boggi U, Menicagli M,
Funel N, Pollera M, Lupi R, Del Guerra S, Bugliani M, Torri S, et
al: Hepatitis C virus infection and human pancreatic beta-cell
dysfunction. Diabetes Care. 28:940–941. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Katakura Y, Yotsuyanagi H, Hashizume K,
Okuse C, Okuse N, Nishikawa K, Suzuki M, Iino S and Itoh F:
Pancreatic involvement in chronic viral hepatitis. World J
Gastroenterol. 11:3508–3513. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Haffar S, Bazerbachi F, Garg S, Lake JR
and Freeman ML: Frequency and prognosis of acute pancreatitis
associated with acute hepatitis E: A systematic review.
Pancreatology. 15:321–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vaghefi M: Nucleoside Triphosphates and
Their Analogs: Chemistry, Biotechnology, and Biological
Applications. CRC press; London: 2016
|
|
45
|
Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen
SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, et al: HCV NS5A
interacts with p53 and inhibits p53-mediated apoptosis. Oncogene.
21:4801–4811. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Niyogi S: Increasing antimicrobial
resistance - an emerging problem in the treatment of shigellosis.
Clin Microbiol Infect. 13:1141–1143. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Baer JT, Vugia DJ, Reingold AL, Aragon T,
Angulo FJ and Bradford WZ: HIV infection as a risk factor for
shigellosis. Emerg Infect Dis. 5:820–823. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Aragón TJ, Vugia DJ, Shallow S, Samuel MC,
Reingold A, Angulo FJ and Bradford WZ: Casecontrol study of
shigellosis in San Francisco: the role of sexual transmission and
HIV infection. Clin Infect Dis. 44:327–334. 2007. View Article : Google Scholar
|
|
49
|
Monaco S, Ferrari S, Gajofatto A, Zanusso
G and Mariotto S: HCV-related nervous system disorders. Clin Dev
Immunol. 2012:2361482012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nimnual A and Bar-Sagi D: The two hats of
SOS. Sci STKE. 2002:pe362002.PubMed/NCBI
|
|
51
|
Cutler RE Jr, Stephens RM, Saracino MR and
Morrison DK: Autoregulation of the Raf-1 serine/threonine kinase.
Proc Natl Acad Sci USA. 95:9214–9219. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Giambartolomei S, Covone F, Levrero M and
Balsano C: Sustained activation of the Raf/MEK/Erk pathway in
response to EGF in stable cell lines expressing the hepatitis C
virus (HCV) core protein. Oncogene. 20:2606–2610. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang Q, Gong R, Qu J, Zhou Y, Liu W, Chen
M, Liu Y, Zhu Y and Wu J: Activation of the Ras/Raf/MEK pathway
facilitates hepatitis C virus replication via attenuation of the
interferon-JAK-STAT pathway. J Virol. 86:1544–1554. 2012.
View Article : Google Scholar :
|
|
54
|
Paul F, Pellegrini S and Uze G: IFNA2: The
prototypic human alpha interferon. Gene. 567:132–137. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Petta S, Bellia C, Mazzola A, Cabibi D,
Cammà C, Caruso A, Di Marco V, Craxì A and Ciaccio M:
Methylenetetrahydrofolate reductase homozygosis and low-density
lipoproteins in patients with genotype 1 chronic hepatitis C. J
Viral Hepat. 19:465–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Adamek A1, Kasprzak A, Mikoś H,
Przybyszewska W, Seraszek-Jaros A, Czajka A, Sterzyńska K and
Mozer-Lisewska I: The insulin-like growth factor-1 and expression
of its binding protein3 in chronic hepatitis C and hepatocellular
carcinoma. Oncol Rep. 30:1337–1345. 2013.PubMed/NCBI
|
|
57
|
Long J, Wang Y, Li M, Tong WM, Jia JD and
Huang J: Correlation of TP53 mutations with HCV positivity in
hepatocarcinogenesis: Identification of a novel TP53 microindel in
hepatocellular carcinoma with HCV infection. Oncol Rep. 30:119–124.
2013. View Article : Google Scholar : PubMed/NCBI
|
